aluates Reports

$ 0.0

Automative

Global Melanoma Skin Cancer Diagnostic Testing Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-30V4764

Global Melanoma Skin Cancer Diagnostic Testing Market Insights Forecast to 2028

BUY CHAPTERS

Global Melanoma Skin Cancer Diagnostic Testing Market Research Report 2025

Code: QYRE-Auto-30V4764

Report

June 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Myriad Genetics

Abbott Laboratories

Foundation Medicine

Pathway Genomics Corporation

Cancer Genetics

Castle Biosciences

NeoGenomics

DermTech

Sysmex Inostics

Melanoma Skin Cancer Diagnostic Testing Market Size

The global market for Melanoma Skin Cancer Diagnostic Testing was valued at US$ 822 million in the year 2024 and is projected to reach a revised size of US$ 1389 million by 2031, growing at a CAGR of 7.9% during the forecast period.

Melanoma Skin Cancer Diagnostic Testing Market

Melanoma skin cancer is the most dangerous type of skin cancer. Development of defective DNA due to exposure to the ultraviolet radiation from sunlight or tanning beds leads to develop melanoma skin cancer. This genetic defect triggers mutation in the cell structure resulting in rapid multiplication of cells forming a malignant tumor. These malignant tumors often originate at basal layer of epidermis which produces melanocyte type of pigment which makes most of melanoma skin cancer black or brown in color. As per skin cancer foundation, in 2018 around 178,560 cases of melanoma will be diagnosed in United States alone. Melanoma skin cancer is the least common type of skin cancer and it is curable if diagnosed early. Early melanoma skin cancer diagnostic testing plays major role future treatment regimen and possible cure for the patient.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Melanoma Skin Cancer Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Skin Cancer Diagnostic Testing.

The Melanoma Skin Cancer Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Melanoma Skin Cancer Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Melanoma Skin Cancer Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Melanoma Skin Cancer Diagnostic Testing Market Report

Report Metric	Details
Report Name	Melanoma Skin Cancer Diagnostic Testing Market
Accounted market size in year	US$ 822 million
Forecasted market size in 2031	US$ 1389 million
CAGR	7.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Biopsy Imaging Others
Segment by Application	Hospitals Dermatology Clinics Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Skin Cancer Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Melanoma Skin Cancer Diagnostic Testing Market growing?

Ans: The Melanoma Skin Cancer Diagnostic Testing Market witnessing a CAGR of 7.9% during the forecast period 2025-2031.

What is the Melanoma Skin Cancer Diagnostic Testing Market size in 2031?

Ans: The Melanoma Skin Cancer Diagnostic Testing Market size in 2031 will be US$ 1389 million.

Who are the main players in the Melanoma Skin Cancer Diagnostic Testing Market report?

Ans: The main players in the Melanoma Skin Cancer Diagnostic Testing Market are Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics

What are the Application segmentation covered in the Melanoma Skin Cancer Diagnostic Testing Market report?

Ans: The Applications covered in the Melanoma Skin Cancer Diagnostic Testing Market report are Hospitals, Dermatology Clinics, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Melanoma Skin Cancer Diagnostic Testing Market report?

Ans: The Types covered in the Melanoma Skin Cancer Diagnostic Testing Market report are Biopsy, Imaging, Others

Recommended Reports

Cancer Diagnostics

Skin Cancer

Personalized Oncology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biopsy

1.2.3 Imaging

1.2.4 Others

1.3 Market by Application

1.3.1 Global Melanoma Skin Cancer Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Dermatology Clinics

1.3.4 Diagnostic Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Perspective (2020-2031)

2.2 Global Melanoma Skin Cancer Diagnostic Testing Growth Trends by Region

2.2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Region (2020-2025)

2.2.3 Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2026-2031)

2.3 Melanoma Skin Cancer Diagnostic Testing Market Dynamics

2.3.1 Melanoma Skin Cancer Diagnostic Testing Industry Trends

2.3.2 Melanoma Skin Cancer Diagnostic Testing Market Drivers

2.3.3 Melanoma Skin Cancer Diagnostic Testing Market Challenges

2.3.4 Melanoma Skin Cancer Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Melanoma Skin Cancer Diagnostic Testing Players by Revenue

3.1.1 Global Top Melanoma Skin Cancer Diagnostic Testing Players by Revenue (2020-2025)

3.1.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Melanoma Skin Cancer Diagnostic Testing Revenue

3.4 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio

3.4.1 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Melanoma Skin Cancer Diagnostic Testing Revenue in 2024

3.5 Global Key Players of Melanoma Skin Cancer Diagnostic Testing Head office and Area Served

3.6 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application

3.7 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Melanoma Skin Cancer Diagnostic Testing Breakdown Data by Type

4.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Type (2020-2025)

4.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2026-2031)

5 Melanoma Skin Cancer Diagnostic Testing Breakdown Data by Application

5.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Application (2020-2025)

5.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size (2020-2031)

6.2 North America Melanoma Skin Cancer Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025)

6.4 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size (2020-2031)

7.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025)

7.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size (2020-2031)

8.2 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Melanoma Skin Cancer Diagnostic Testing Market Size (2020-2031)

9.2 Latin America Melanoma Skin Cancer Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025)

9.4 Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size (2020-2031)

10.2 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Details

11.1.2 Myriad Genetics Business Overview

11.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Introduction

11.1.4 Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.1.5 Myriad Genetics Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Introduction

11.2.4 Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.2.5 Abbott Laboratories Recent Development

11.3 Foundation Medicine

11.3.1 Foundation Medicine Company Details

11.3.2 Foundation Medicine Business Overview

11.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Introduction

11.3.4 Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.3.5 Foundation Medicine Recent Development

11.4 Pathway Genomics Corporation

11.4.1 Pathway Genomics Corporation Company Details

11.4.2 Pathway Genomics Corporation Business Overview

11.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Introduction

11.4.4 Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.4.5 Pathway Genomics Corporation Recent Development

11.5 Cancer Genetics

11.5.1 Cancer Genetics Company Details

11.5.2 Cancer Genetics Business Overview

11.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Introduction

11.5.4 Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.5.5 Cancer Genetics Recent Development

11.6 Castle Biosciences

11.6.1 Castle Biosciences Company Details

11.6.2 Castle Biosciences Business Overview

11.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Introduction

11.6.4 Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.6.5 Castle Biosciences Recent Development

11.7 NeoGenomics

11.7.1 NeoGenomics Company Details

11.7.2 NeoGenomics Business Overview

11.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Introduction

11.7.4 NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.7.5 NeoGenomics Recent Development

11.8 Dermtech

11.8.1 Dermtech Company Details

11.8.2 Dermtech Business Overview

11.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Introduction

11.8.4 Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.8.5 Dermtech Recent Development

11.9 Sysmex Inostics

11.9.1 Sysmex Inostics Company Details

11.9.2 Sysmex Inostics Business Overview

11.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Introduction

11.9.4 Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

11.9.5 Sysmex Inostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Myriad Genetics

Abbott Laboratories

Foundation Medicine

Pathway Genomics Corporation

Cancer Genetics

Castle Biosciences

NeoGenomics

DermTech

Sysmex Inostics

List of Tables

Table 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biopsy

Table 3. Key Players of Imaging

Table 4. Key Players of Others

Table 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2020-2025)

Table 9. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2026-2031)

Table 11. Melanoma Skin Cancer Diagnostic Testing Market Trends

Table 12. Melanoma Skin Cancer Diagnostic Testing Market Drivers

Table 13. Melanoma Skin Cancer Diagnostic Testing Market Challenges

Table 14. Melanoma Skin Cancer Diagnostic Testing Market Restraints

Table 15. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players (2020-2025)

Table 17. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2024)

Table 18. Ranking of Global Top Melanoma Skin Cancer Diagnostic Testing Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Headquarters and Area Served

Table 21. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application

Table 22. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2020-2025)

Table 26. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2026-2031)

Table 28. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application (2020-2025)

Table 30. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application (2026-2031)

Table 32. North America Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 47. Myriad Genetics Company Details

Table 48. Myriad Genetics Business Overview

Table 49. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product

Table 50. Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 51. Myriad Genetics Recent Development

Table 52. Abbott Laboratories Company Details

Table 53. Abbott Laboratories Business Overview

Table 54. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product

Table 55. Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 56. Abbott Laboratories Recent Development

Table 57. Foundation Medicine Company Details

Table 58. Foundation Medicine Business Overview

Table 59. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product

Table 60. Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 61. Foundation Medicine Recent Development

Table 62. Pathway Genomics Corporation Company Details

Table 63. Pathway Genomics Corporation Business Overview

Table 64. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product

Table 65. Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 66. Pathway Genomics Corporation Recent Development

Table 67. Cancer Genetics Company Details

Table 68. Cancer Genetics Business Overview

Table 69. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product

Table 70. Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 71. Cancer Genetics Recent Development

Table 72. Castle Biosciences Company Details

Table 73. Castle Biosciences Business Overview

Table 74. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product

Table 75. Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 76. Castle Biosciences Recent Development

Table 77. NeoGenomics Company Details

Table 78. NeoGenomics Business Overview

Table 79. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product

Table 80. NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 81. NeoGenomics Recent Development

Table 82. Dermtech Company Details

Table 83. Dermtech Business Overview

Table 84. Dermtech Melanoma Skin Cancer Diagnostic Testing Product

Table 85. Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 86. Dermtech Recent Development

Table 87. Sysmex Inostics Company Details

Table 88. Sysmex Inostics Business Overview

Table 89. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product

Table 90. Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 91. Sysmex Inostics Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Melanoma Skin Cancer Diagnostic Testing Picture

Figure 2. Global Melanoma Skin Cancer Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Type: 2024 VS 2031

Figure 4. Biopsy Features

Figure 5. Imaging Features

Figure 6. Others Features

Figure 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Dermatology Clinics Case Studies

Figure 11. Diagnostic Laboratories Case Studies

Figure 12. Others Case Studies

Figure 13. Melanoma Skin Cancer Diagnostic Testing Report Years Considered

Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region: 2024 VS 2031

Figure 17. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players in 2024

Figure 18. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2024

Figure 20. North America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2020-2031)

Figure 22. United States Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2020-2031)

Figure 26. Germany Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2020-2031)

Figure 34. China Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2020-2031)

Figure 42. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2020-2031)

Figure 46. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Myriad Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 50. Abbott Laboratories Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 51. Foundation Medicine Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 52. Pathway Genomics Corporation Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 53. Cancer Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 54. Castle Biosciences Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 55. NeoGenomics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 56. Dermtech Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 57. Sysmex Inostics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Skin Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Metastatic Melanoma Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mobile Applications for Melanoma Detection Market Research Report 2024

Global Melanoma Diagnostics and Therapeutics Market Research Report 2024

Global Skin Cancer Diagnostic Equipment Market Research Report 2024

Global Skin Cancer Therapeutics Market Research Report 2024

Global Skin Cancer Molecular Diagnostics Market Research Report 2024

Global Skin Cancer Diagnostic Tool Market Research Report 2025

Melanoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Melanoma Molecular Diagnostics Market Research Report 2024

Global Non Melanoma Skin Cancer Market Research Report 2024

Global Dermatology Diagnostics Devices Market Insights Forecast to 2030

Basal Cell Carcinoma Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Handheld Melanoma Scanner Market Research Report 2024

Global Non Melanoma Skin Cancer Treatment Market Research Report 2024

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2025

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Global Breast Cancer Testing Market Insights Forecast to 2030

Global Tumor Marker Testing Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions